노보 노르디스크(NVO)는 NYSE에 상장된 Healthcare · Drug Manufacturers - General 기업입니다. 현재가 $43.24 (+0.12%), 시가총액 $198.26B, PER (주가수익비율) 10.38, 52주 최저~최고 $35.29 ~ $81.05.
Novo Nordisk A/S, together with its subsidiaries, engages in the research and development, manufacture, and distribution of pharmaceutical products. It operates through two segments, Obesity and Diabetes Care, and Rare Disease. The Obesity and Diabetes care segment provides products for diabetes, obesity, cardiovascular, and other emerging therapy areas. The Rare Disease segment offers products in the areas of rare blood disorders, rare endocrine disorders, and hormone replacement therapy. The company also provides NovoPen 6 and NovoPen Echo Plus, smart insulin pens; Dose Check, an insulin dose guidance application; and growth hormone pens and injection needles. It operates in Europe, Canada
노보 노르디스크의 재무제표, 목표주가, 기관투자자(13F) 보유 현황, 관련 뉴스는 BlackAll Trade에서 실시간으로 확인할 수 있습니다.
최근 토론 4건 · 강세 4 · 약세 0 · 중립 0.
노보 노르디스크의 현재 주가는 $43.24 (+0.12%)입니다. BlackAll Trade에서 실시간 시세와 차트를 확인할 수 있습니다.
노보 노르디스크의 시가총액은 약 $198.26B입니다. PER은 10.38입니다.
Novo Nordisk A/S, together with its subsidiaries, engages in the research and development, manufacture, and distribution of pharmaceutical products. It operates through two segments, Obesity and Diabe